Expansion Strategy Waters to Acquire Lab Automation Technology Firm Andrew Alliance
With the takeover of Andrew Alliance, Waters Corporation intends to strengthen its core business of analytical system solutions and also expand its technology portfolio for the benefit of its customers across the pharmaceutical, life sciences and materials science industries.
Massachusetts/USA – Waters Corporation has recently announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling more scientists to realise the advantages of repeatability and performance for both routine and complex laboratory workflows.
“The acquisition of Andrew Alliance broadens our technology portfolio to include advanced robotics and software that will positively impact our customers’ workflows across pharmaceuticals, life sciences and materials science markets,” commented Chris O’Connell, Chairman and Chief Executive Officer of Waters Corporation. “This move also demonstrates Waters’ commitment to deploy capital to growth-oriented acquisitions that reinforce our specialty strategy and enhance our core business.”
Andrew Alliance has approximately 40 employees in Switzerland, France and the United States.
“We are thrilled to join the Waters family,” commented Piero Zucchelli, Chief Executive Officer of Andrew Alliance. “We have found the right partner to bring our vision of connected laboratories to life. Waters’ combination of instruments and chemistries will help us accelerate the delivery of our innovative software and hardware technologies to customers as mass spectrometry increasingly moves into the hands of more and more users.”